Point Nemo Capital »

Halozyme Therapeutics shares owned by Point Nemo Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Point Nemo Capital from 13F filings

Historical chart of Point Nemo Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Point Nemo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Point Nemo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $939 12 78.25
2025-12-31 $691k 10k 67.30

More positions owned by Point Nemo Capital

Ishares Convertible Bondetf Uit Exchange Traded (ICVT)
Ishares Msci South Koreaetf Uit Exchange Traded (EWY)
Vaneck Rare Earth And Strategic Metals Etf Uit Exchange Traded (REMX)
Vanguard Total Stock Mkt Idx Adm Equity Funds (VTSAX)
Ishares Msci Taiwan Etf Uit Exchange Traded (EWT)
Proshares K-1 Free Crudeoil Etf Uit Exchange Traded (OILK)
Ishares Global Clean Energy Etf Uit Exchange Traded (ICLN)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Uit Exchange Traded (PDBC)
Global X Mlp Etf Uit Exchange Traded (MLPA)
State Street Technology Select Sector Spdr Etf Uit Exchange Traded (XLK)
State Street Energy Select Sector Spdr Etf Uit Exchange Traded (XLE)
Ishares Mortgage Real Estate Capped Etf Uit Exchange Traded (REM)
Vanguard Total Stock Market Etf Uit Exchange Traded (VTI)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Uit Exchange Traded (BIL)
Space Ex Tech Spacex Class A Common Stock (SPCK)

View all positions for Point Nemo Capital

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Robeco Investment Management
Bank of America Corporation
Morgan Stanley
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management

View all funds holding Halozyme Therapeutics